Glenmark Pharmaceuticals Ltd. (Glenmark), pharmaceutical company, has launched India’s first topical Minocycline 4% Gel for the treatment of moderate to severe acne, under the brand name MINYM®.
According to a press release from the company, this is a potent antibacterial gel which exerts a strong anti-inflammatory action It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90% of isolates of bacteria) compared to the available topical antibacterial formulations.
MINYM® Gel (Topical Minocycline 4% Gel) has been developed to address these growing concerns in treatment of acne and is safe to use in patients above 9 years of age said, Alok Malik, Group Vice President & Head, India Formulations – Glenmark.